Stop Childrens Cancer Inc
- Assets
- $1.7m
- Revenue
- $630.3k
- Investments
- $0.0
- Employees
- 2
- Location
- Gainesville, FL
- Founding
- 05/1986
- Data as of
- 12/2023
- EIN
- 59-2624901
Organization Overview
Stop Childrens Cancer Inc is located in Gainesville, FL. The organization was established in 1986. According to its NTEE Classification (G30) the organization is classified as: Cancer, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 12/2023, Stop Childrens Cancer Inc employed 2 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Stop Childrens Cancer Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Stop Childrens Cancer Inc generated $630.3k in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 7.1% each year. All expenses for the organization totaled $497.0k during the year ending 12/2023. While expenses have increased by 6.6% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF STOP CHILDREN'S CANCER IS THE PREVENTION, CONTROL AND CURE OF CHILDHOOD CANCERS. FUNDS ARE RAISED ANNUALLY AND AWARDED TO SELECTED RESEARCH AGENCIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SINCE ITS INCEPTION IN 1981, STOP CHILDREN'S CANCER HAS RAISED OVER $7 MILLION, INCLUDING THE BONNIE'S LEGACY ENDOWMENT FUND WHICH HAS APPROXIMATELY $1 MILLION IN PERPETUITY. IN ADDITION, AS A RESULT OF THESE DONATIONS, WELL IN EXCESS OF $18 MILLION IN NATIONAL CANCER INSTITUTE/NATIONAL INSTITUTE OF HEALTH (NIH) GRANTS AND OTHER AWARDS HAVE BEEN AWARDED.STOP CHILDREN'S CANCER / BONNIE R. FREEMAN CLINICAL TRIAL FUND:THIS FUND CONTINUES TO SUPPORT THE PROGRAM INFRASTRUCTURE, INCLUDING THE DIRECTOR'S POSITION WHO HAS LED OUR EFFORTS IN GROWING THE PEDIATRIC CANCER TRIALS. THIS INCLUDES ENROLLING 55 CHILDREN ON PEDIATRIC CANCER TREATMENT TRIALS, 84 PATIENTS ON BASIC SCIENCE, SUPPORTIVE CARE, OR SURVIVORSHIP STUDIES, AND AN ADDITIONAL 64 ENROLLED ON THE CHILDREN'S ONCOLOGY GROUP REGISTRY AND BIOLOGY STUDY DURING THE ACADEMIC YEAR. STOP CHILDREN'S CANCER / KIMBERLY H. FLAITZ RESEARCH GRANT:A KEY GOAL OF THIS RESEARCH FUND WAS TO SUPPORT WORK ON DEVELOPING VACCINES FOR PEDIATRIC OSTEOSARCOMA WITH THE ULTIMATE GOAL OF OPENING A TRIAL USING ONE OF THESE TECHNOLOGIES IN CHILDREN. THE FUNDING CONTINUED TO SUPPORT THE SALARY OF DR. MATTHEW CASCIO WORKING ON DEVELOPING LIPID-NANOPARTICLE(NP) VACCINES AND CAR T CELL IMMUNOTHERAPY. IN PARTNERSHIP WITH DRS. CASCIO AND MILNER (MENTOR), WE HAVE ESTABLISHED A JOINT PEDIATRIC AND LARGE-ANIMAL CANCER IMMUNOTHERAPY PROGRAM. TOGETHER WE HAVE MANUFACTURED CLINICAL GRADE LIPID-NANOPARTICLE VACCINES. IN PET-DOGS WITH SPONTANEOUSLY OCCURRING OSA, WE HAVE SHOWN THAT LIPID-NP VACCINES ELICIT IMMUNE RESPONSES WITH IMPROVING THE DOGS' LONG-TERM SURVIVAL.LYRICS FOR LIFE / STOP CHILDREN'S CANCER JEFFREY A. BLOCK RESEARCH GRANT:THIS FUNDING SUPPORTED DR. PAUL CASTILLO, WHO IS WORKING ON DEVELOPING NOVEL IMMUNOTHERAPIES TO TREAT REFRACTORY CANCERS, ESPECIALLY T-CELL LEUKEMIAS AND T-CELL LYMPHOMAS. GIVEN THE STRIKING RESULTS OF A COMBINATIONAL APPROACH USING CAR T CELLS AND RNA NANOPARTICLE-BASED VACCINES, HE CONTINUES HIS WORK USING THIS APPROACH THAT WAS REPORTED IN 2021. HE HAS SHOWN PROMISING DATA USING THIS IMMUNOTHERAPEUTIC COMBINATIONAL APPROACH FOR ACUTE MYELOID LEUKEMIA, METASTATIC OSTEOSARCOMA, AND METASTATIC MELANOMA. THE PROMISE OF THIS APPROACH IS THAT IT CONTINUES TO HOLD ANTICANCER EFFICACY FOR A WIDE RANGE OF CANCERS. THIS FUNDING ALSO SUPPORTED A REVIEW PAPER THAT WAS PUBLISHED, DESCRIBING TUMOR MODELS FOR EVALUATION OF CAR T CELLS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Phyllis Baucom Secretary | OfficerTrustee | 1 | $0 |
Lynn Bennett Board Member | Trustee | 1 | $0 |
Jim Brandenburg Vice President | OfficerTrustee | 1 | $0 |
Becky DE Marie Board Member | Trustee | 1 | $0 |
Pat Dooley Board Member | Trustee | 1 | $0 |
Beth Flaitz Board Member | Trustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $326,041 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $223,610 |
| Noncash contributions included in lines 1a–1f | $98,370 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $549,651 |
| Total Program Service Revenue | $0 |
| Investment income | $42,281 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$24,937 |
| Net Income from Fundraising Events | $63,256 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $630,251 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $300,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $69,068 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $5,293 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $271 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $5,251 |
| Fees for services: Other | $0 |
| Advertising and promotion | $477 |
| Office expenses | $91,001 |
| Information technology | $5,403 |
| Royalties | $0 |
| Occupancy | $3,092 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $5,604 |
| Insurance | $3,231 |
| All other expenses | $0 |
| Total functional expenses | $497,029 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $214,122 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $98,100 |
| Investments—publicly traded securities | $1,426,657 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $1,738,879 |
| Accounts payable and accrued expenses | $1,541 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $1,541 |
| Net assets without donor restrictions | $1,737,338 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,738,879 |